IPO Profile: Roka Bioscience Inc

Asiling, NEA, OrbiMed, TPG and other investors saw a 10.16x return on the Warren, N.J.-based company

ByLarry Oberfeld

1 August 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.